25.12.2012 Views

revised final - Agency for Toxic Substances and Disease Registry ...

revised final - Agency for Toxic Substances and Disease Registry ...

revised final - Agency for Toxic Substances and Disease Registry ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

MERCURY 196<br />

2. HEALTH EFFECTS<br />

dosing. The latter is of direct relevance to methylmercury risk assessments currently based on human<br />

studies of short-term exposures, while the general public exposure is more typically continuous. Neither<br />

model ran simulations nor validated against data <strong>for</strong> other species (including human). Nor did the models<br />

address high-to-low dose extrapolations or different routes of exposure.<br />

2.3.5.3 Discussion of Models<br />

The Farris et al. Model <strong>for</strong> Methylmercury. The Farris et al. (1993) model is a physiologically<br />

based model that simulates the long-term disposition of methylmercury <strong>and</strong> its primary biotrans<strong>for</strong>mation<br />

product, mercuric mercury, in growing mammals following a single nontoxic oral dose of the parent<br />

compound. The test animal used to develop <strong>and</strong> validate the model was the male Sprague-Dawley rat. A<br />

tracer dose was used in the validation studies to preclude the possibility that the results would be biased by<br />

toxic or saturation effects. The model incorporates a number of features, including a time-dependent<br />

compartment <strong>for</strong> volume changes (i.e., the rats grew from 300 to 500 g in body weight over the 98-day time<br />

course of the validation study), compartment volume-dependent clearances, <strong>and</strong> the recycling of mercury<br />

from ingestion of hair by rats during grooming.<br />

Risk assessment. The Farris et al. model has not been used in human risk assessment. The authors,<br />

however, suggest that the model would be useful in developing a better underst<strong>and</strong>ing of species differences<br />

<strong>and</strong> in predicting the affects of altered biochemical or physiological states on methylmercury pharmacokinetics.<br />

For example, the authors suggest that the model can be adapted to simulate data <strong>for</strong> neonatal<br />

animals or humans that are known to secrete glutathione poorly. It could also help elucidate the mercury<br />

kinetics <strong>for</strong> animals that have altered bile flow or that have nonabsorbable sulfhydryl-containing resins.<br />

Description of the model. The Farris et al. model consists of nine lumped compartments, each of<br />

which represent a major site of mercury accumulation, elimination, or effect in mammals. The<br />

compartment labeled “carcass” is a residual compartment <strong>and</strong> consists of all tissues <strong>and</strong> organs not<br />

specifically represented by the other eight compartments in the model. A flow diagram of the model is<br />

shown in Figure 2-5. The interdepartmental mass transport parameters used in the model are shown in<br />

Table 2-6.<br />

Methylmercury transport between all compartments except brain <strong>and</strong> hair is modeled as plasma flow limited<br />

(i.e., plasma levels rapidly equilibrate with erythrocytes). Mercuric mercury transport parameters

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!